Gene expression profiling of the ADRB2 silenced LNCaP cells revealed that UDP-glucuronosyltransferase (UGT) 2B15 and 2B17 were down-regulated; these enzymes control androgen inactivation in prostate cancer [63]. Here, ADRB2 is linked to prostate carcinoma.